The Second European Endoscopy Forum  (Sintra, Portugal, 17 - 18 June 1999):  Twenty Questions on the Esophagogastric Junction

A. Axon; R. Lambert; M. Robaszkiewicz; T. Rösch; A. Sonnenberg

doi:10.1055/s-2000-8998

Endoscopy, Table of Contents

Endoscopy 2000; 32(5): 411-418
DOI: 10.1055/s-2000-8998

ESGE Opinion Paper

Georg Thieme Verlag Stuttgart · New York

The Second European Endoscopy Forum (Sintra, Portugal, 17 - 18 June 1999): Twenty Questions on the Esophagogastric Junction

A. Axon ¹ , R. Lambert ² , M. Robaszkiewicz ³ , T. Rösch ⁴ , A. Sonnenberg ⁵

¹ Division of Gastroenterology, The General Infirmary, Leeds, United Kingdom
² Department of Digestive Diseases, Hospital E. Herriot, Lyon, France
³ Department of Gastroenterology, CHU de la Cavale Blanche, Brest, France
⁴ Department of Internal Medicine II, Technical University of Munich, Germany
⁵ Department of Radiology, The University of Texas Medical Branch, Galveston, Texas, USA

Abstract

Full Text

References

1 Barrett NR. The lower oesophagus lined by columnar epithelium. Surgery. 1957; 41 881-894
2 Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA. Prevalence of columnar-lined Barrett's esophagus: comparison of population based clinical and autopsy findings. Gastroenterology. 1990; 99 918-922
3 Chalsani N, Woo JM, Hunter JG, Waring SP. Significance of intestinal metaplasia in different areas of the oesophagus including oesophagogastric junction. Dig Dis Sci. 1997; 42 603-607
4 Hirota WK, Loughney TM, Lazas DJ, et al. Specialized intestinal metaplasia, dysplasia and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology. 1999; 116 277-285
5 Iascone C, DeMeester TR, Little AG, Skinner DB. Barrett's esophagus: functional assessment, proposed pathogenesis, and surgical therapy. Arch Surg. 1983; 118 543-549
6 Kahrilas PJ. Anatomy and physiology of the gastroesophageal junction. Gastroenterol Clin North Am. 1997; 3 467-485
7 Levine DS. Management of dysplasia in the columnar-lined esophagus. Gastroenterol Clin North Am. 1997; 3 613-634
8 Ormsby AH, Goldblum JR, Richter JE, et al. Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach. Hum Pathol. 1999; 30 288-294
9 Spechler SJ. The columnar-lined esophagus: histology, terminology and clinical issues. Gastroenterol Clin North Am. 1997; 26 445-466
10 Spechler SJ. The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction. Gastroenterology. 1999; 117 218-228
11 Spechler SJ, Goyal RK. Barrett's esophagus. N Engl J Med. 1986; 315 362-371
12 Van der Burgh A, Dees J, Hopp WCJ, van Blankenstein M. Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. Gut. 1996; 39 5-8
13 Wijnhoven BP, Siersema PD, Hop WC, et al. Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity (Rotterdam Oesophageal Tumour Group). Br J Surg. 1999; 86 529-535
14 Wright TA. High-grade dysplasia in Barrett's oesophagus. Br J Surg. 1997; 84 760-766
15 Bytzer P, Christensen PB, Damkier P, et al. Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study. Am J Gastroenterol. 1999; 94 86-91
16 Devesa SS, Blot WJ, Fraumeni JF. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998; 83 2049-2053
17 Dolan K, Sutton R, Walker SJ, et al. New classification of oesophageal and gastric carcinomas derived from changing patterns in epidemiology. Br J Cancer. 1999; 80 834-842
18 Hansen S, Wiig JN, Giercksky KE, Tretli S. Esophageal and gastric carcinoma in Norway, 1958 - 1992: incidence, time trend variability according to morphological subtypes and organ subsites. Int J Cancer. 1997; 71 340-344
19 National Cancer Institute. Surveillance, Epidemiology, and End Results. SEER*Stat for Windows 95/NT, Version 1.1: SEER cancer incidence public-use database, 1993 - 1995. Bethesda, MD; US Department of Health and Human Services, 1997
20 Champion G, Richter JE, Vaezi MF, et al. Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus. Gastroenterology. 1994; 107 747-754
21 Collen MJ, Lewis JH, Benjamin SB. Gastric acid hypersecretion in refractory gastroesophageal reflux disease. Gastroenterology. 1990; 98 654-661
22 Eisen GM, Sandler RS, Murray S, Gottfried M. The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus. Am J Gastroenterol. 1997; 92 27-31
23 El-Serag HB, Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut. 1998; 43 333
24 El-Serag HB, Sonnenberg A. Associations among different forms of gastroesophageal reflux disease. Gut. 1997; 41 594-599
25 Galmiche JP, Janssens J. The pathophysiology of gastro-oesophageal reflux disease: an overview. Scand J Gastroenterol. 1995; 30 (Suppl 211) 7-18
26 Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999; 340 825-831
27 Nebel OT, Fornes MF, Castell DO. Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis. 1976; 21 953-956
28 Sonnenberg A, El-Serag HB. Epidemiology of gastroesophageal reflux disease. In: Büchler MW, Farthmann EH Progress in Surgery, vol. 23. Basle; Karger 1997: 36
29 Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ III. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology. 1992; 102 1259-1268
30 Burtin P, Napoleon B, Palazzo L, et al. Interobserver agreement in endoscopic ultrasonography staging of esophageal and cardia cancer. Gastrointest Endosc. 1996; 43 20-24
31 Canto M. Vital staining and Barrett's esophagus. Gastrointest Endosc. 1999; 49 6
32 Eloubeidi MA, Provenzale D. Does this patient have Barrett's esophagus? The utility of predicting Barrett's esophagus at the index endoscopy. Am J Gastroenterol. 1999; 94 937-943
33 Ellis KK, Oehlke M, Helfand M, Lieberman D. Management of symptoms of gastroesophageal reflux disease: does endoscopy influence medical management?. Am J Gastroenterol. 1997; 92 1472-1474
34 Ellis FH, Loda M. Role of surveillance endoscopy, biopsy and biomarkers in early detection of Barrett' s adenocarcinoma. Dis Esophagus. 1997; 10 165-171
35 Murata Y. The role of endoscopic ultrasonography for gastric cancer in the cardiac area [in Japanese]. Nippon Geka Gakkai Zasshi. 1998; 99 564-568
36 Tytgat GN. Does endoscopic surveillance in esophageal columnar metaplasia (Barrett's esophagus) have any value?. Endoscopy. 1995; 27 19-26
37 Tytgat GN. Endoscopic features of the columnar-lined esophagus. Gastroenterol Clin North Am. 1997; 3 507-517
38 Fennerty MB. Perspectives on endoscopic eradication of Barrett's esophagus: who are appropriate candidates and what is the best method?. Gastrointest Endosc. 1999; 49 (3) 24-28
39 Gossner L, Stolte M, Sroka R, et al. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. Gastroenterology. 1998; 114 448-455
40 Lightdale CJ. Ablation therapy for Barrett's esophagus: is it time to choose our weapons?. Gastrointest Endosc. 1999; 49 122-125
41 Overholt BF, Panjehpour M, Haydek JM. Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointest Endosc. 1999; 49 1-7
42 Van den Boogert J, van Hillegersberg R, Siersema PD, et al. Endoscopic ablation therapy for Barrett's esophagus with high-grade dysplasia: a review. Am J Gastroenterol. 1999; 94 1153-1160
43 Van Laethem JL, Cremer M, Peny MO, et al. Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: immediate and mid-term results. Gut. 1998; 43 747-751
44 Provenzale D, Kemp JA, Arora S, Wong JB. A guide for surveillance of patients with Barrett's esophagus. Am J Gastroenterol. 1994; 89 670-680
45 Sonnenberg A. Esophageal diseases. In: Everhart JE Digestive diseases in the United States: epidemiology and impact (US Department of Health and Human Services, NIH publication no. 94-1447). Washington, DC; US Government Printing Office 1994: 356
46 Sonnenberg A, El-Serag HB. Economic aspects of endoscopic screening for intestinal precancerous conditions. Gastrointest Endosc Clin North Am. 1997; 7 165-184
47 Sonnenberg A, Delco F, El-Serag HB. Empirical therapy versus diagnostic tests in gastroesophageal reflux disease: a medical decision analysis. Dig Dis Sci. 1998; 43 1001-1008
48 Wright TA, Gray MR, Morris AI, et al. Cost-effectiveness of detecting Barrett's cancer. Gut. 1996; 39 574-579

M.D. R. Lambert

International Agency for Research on Cancer

150, Cours A. Thomas

Lyon 69003

France

Phone: +33-4-72110147

Email: lambert@iarc. fr